Epidemiology and genetic susceptibility to bladder cancer

BJU International

Volumn 102, Issue 9B, 2008, Pages 1207-1215

  Wu, Xifeng ^a   Ros, Martine M ^b,c   Gu, Jian ^a   Kiemeney, Lambertus ^b  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^b RADBOUD UNIVERSITY MEDICAL CENTER   (Netherlands)

^c NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

Author keywords

Bladder cancer; Epidemiology; Risk factors

Indexed keywords

ACROLEIN; ARSENIC; CARCINOGEN; CYCLOPHOSPHAMIDE; DRINKING WATER; HAIR DYE; MELPHALAN; PHENACETIN; THIOTEPA;

BLADDER CANCER; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CANCER SUSCEPTIBILITY; ENVIRONMENTAL FACTOR; FLUID INTAKE; FOOD INTAKE; FRUIT; GENE INTERACTION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENETIC VARIABILITY; HEREDITY; HUMAN; KIDNEY PELVIS CARCINOMA; LIFESTYLE; MEDICAL PRACTICE; OCCUPATIONAL EXPOSURE; ONCOGENE; PELVIS; PENETRANCE; PHENOTYPE; PRIORITY JOURNAL; RADIATION EXPOSURE; RELATIVE; REVIEW; RISK ASSESSMENT; SCHISTOSOMA HEMATOBIUM; SCHISTOSOMIASIS; SMOKING; URETER CARCINOMA; URINARY TRACT INFECTION; VEGETABLE; WATER QUALITY; WESTERN HEMISPHERE;

FEMALE; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INCIDENCE; MALE; OCCUPATIONAL EXPOSURE; RISK ASSESSMENT; RISK FACTORS; SMOKING; URINARY BLADDER NEOPLASMS;

EID: 54049104346     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07961.x     Document Type: Review

References (102)

1. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005 55 : 74 108
2. IARC. Cancer incidence in five continents Vol. VIII. IARC Sci Publ 2002 155 : 1 781.
3. IARC. Cancer Incidence in Five Continents. IARC, 2007. Available at: http://www-Dep.fr/. Accessed Dec 2007
4. Prout GR Wesley MN, McCarron PG et al. Survival experience of black patients and white patients with bladder carcinoma. Cancer 2004 100 : 621 30
5. Silverman DT, Devesa SS, Moore LE, Rothman N. Bladder cancer. In Schottenfeld D, Fraumeni JF Jr eds, Cancer Epidemiology and Prevention. New York : Oxford University Press, 2006 : 1101 27
6. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000 89 : 630 9
7. Bjerregaard BK, Raaschou-Nielsen O, Sorensen M et al. The effect of occasional smoking on smoking-related cancers: in the European Prospective Investigation into Cancer and Nutrition (EPIC). Cancer Causes Control 2006 17 : 1305 9
8. Brennan P, Bogillot O, Cordier S et al. Cigarette smoking and bladder cancer in men: a pooled analysis of 11 case-control studies. Int J Cancer 2000 86 : 289 94
9. Samanic C, Kogevinas M, Dosemeci M et al. Smoking and bladder cancer in Spain: effects of tobacco type, timing, environmental tobacco smoke, and gender. Cancer Epidemiol Biomarkers Prev 2006 15 : 1348 54
10. Clavel J, Cordier S, Boccon-Gibod L, Hemon D. Tobacco and bladder cancer in males: increased risk for inhalers and smokers of black tobacco. Int J Cancer 1989 44 : 605 10
11. D'Avanzo B, Negri E, La Vecchia C et al. Cigarette smoking and bladder cancer. Eur J Cancer 1990 26 : 714 8
12. Ferlay J, Randi G, Bosetti C et al. Declining mortality from bladder cancer in Europe. BJU Int 2008 101 : 11 9
13. Vineis P, Simonato L. Proportion of lung and bladder cancers in males resulting from occupation: a systematic approach. Arch Environ Health 1991 46 : 6 15
14. Serra C, Kogevinas M, Silverman DT et al. Work in the textile industry in Spain and bladder cancer. Occup Environ Med 2008 65 : 552 9
15. Markowitz SB, Levin K. Continued epidemic of bladder cancer in workers exposed to ortho-toluidine in a chemical factory. J Occup Environ Med 2004 46 : 154 60
16. Bosetti C, Pira E, La Vecchia C. Bladder cancer risk in painters: a review of the epidemiological evidence, 1989-2004. Cancer Causes Control 2005 16 : 997 1008
17. Gaertner RR, Theriault GP. Risk of bladder cancer in foundry workers: a meta-analysis. Occup Environ Med 2002 59 : 655 63
18. Boffetta P, Silverman DT. A meta-analysis of bladder cancer and diesel exhaust exposure. Epidemiology 2001 12 : 125 30
19. Samanic CM, Kogevinas M, Silverman DT et al. Occupation and bladder cancer in a hospital-based case-control study in Spain. Occup Environ Med 2008 65 : 347 53
20. Kogevinas M, t'Mannetje A, Cordier S et al. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control 2003 14 : 907 14
21. Ranmuthugala G, Pilotto L, Smith W, Vimalasiri T, Dear K, Douglas R. Chlorinated drinking water and micronuclei in urinary bladder epithelial cells. Epidemiology 2003 14 : 617 22
22. King WD, Marrett LD. Case-control study of bladder cancer and chlorination by-products in treated water (Ontario, Canada). Cancer Causes Control 1996 7 : 596 604
23. Koivusalo M, Hakulinen T, Vartiainen T, Pukkala E, Jaakkola JJ, Tuomisto J. Drinking water mutagenicity and urinary tract cancers: a population-based case-control study in Finland. Am J Epidemiol 1998 148 : 704 12
24. McGeehin MA, Reif JS, Becher JC, Mangione EJ. Case-control study of bladder cancer and water disinfection methods in Colorado. Am J Epidemiol 1993 138 : 492 501
25. IARC. Some Chemicals that Cause Tumors of the Kidney or Urinary Bladder in Rodents and Some Other Substances, Cobalt and Cobalt Compounds. IARC Monographs on the Evaluation of Carcinogenic Risks to Humans. Lyon : IARC, 1999
26. Anonymous. International Programme on chemical safety (IPCS). Disinfectant and Disinfectant by-products. Environmental Health Criteria 216. Geneva : United Nations Environment Programme, International Labour Organization, WHO, 2004. Available at: http://www.who.int/ipcs/publications/ehc/ ehc_216/en/index.html. Accessed Nov 2004
27. Villanueva CM, Cantor KP, Cordier S et al. Disinfection byproducts and bladder cancer: a pooled analysis. Epidemiology 2004 15 : 357 67
28. Chen CJ, Chuang YC, You SL, Lin TM, Wu HY. A retrospective study on malignant neoplasms of bladder, lung and liver in blackfoot disease endemic area in Taiwan. Br J Cancer 1986 53 : 399 405
29. Anawar HM, Akai J, Mostofa KM, Safiullah S, Tareq SM. Arsenic poisoning in groundwater: health risk and geochemical sources in Bangladesh. Environ Int 2002 27 : 597 604
30. Kunze E, Chang-Claude J, Frentzel-Beyme R. Life style and occupational risk factors for bladder cancer in Germany. A case-control study. Cancer 1992 69 : 1776 90
31. Villanueva CM, Cantor KP, King WD et al. Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer 2006 118 : 2040 7
32. Michaud DS, Kogevinas M, Cantor KP et al. Total fluid and water consumption and the joint effect of exposure to disinfection by-products on risk of bladder cancer. Environ Health Perspect 2007 115 : 1569 72
33. Michaud DS, Spiegelman D, Clinton SK et al. Fluid intake and the risk of bladder cancer in men. N Engl J Med 1999 340 : 1390 7
34. Kantor AF, Hartge P, Hoover RN, Narayana AS, Sullivan JW, Fraumeni JF Jr. Urinary tract infection and risk of bladder cancer. Am J Epidemiol 1984 119 : 510 5
35. Pannek J. Transitional cell carcinoma in patients with spinal cord injury: a high risk malignancy? Urology 2002 59 : 240 4
36. Groah SL, Weitzenkamp DA, Lammertse DP, Whiteneck GG, Lezotte DC, Hamman RF. Excess risk of bladder cancer in spinal cord injury: evidence for an association between indwelling catheter use and bladder cancer. Arch Phys Med Rehabil 2002 83 : 346 51
37. McCredie M, Stewart JH, Ford JM, MacLennan RA. Phenacetin-containing analgesics and cancer of the bladder or renal pelvis in women. Br J Urol 1983 55 : 220 4
38. Fortuny J, Kogevinas M, Garcia-Closas M et al. Use of analgesics and nonsteroidal anti-inflammatory drugs, genetic predisposition, and bladder cancer risk in Spain. Cancer Epidemiol Biomarkers Prev 2006 15 : 1696 702
39. Travis LB, Curtis RE, Glimelius B et al. Bladder and kidney cancer following cyclophosphamide therapy for non-Hodgkin's lymphoma. J Natl Cancer Inst 1995 87 : 524 30
40. Kaldor JM, Day NE, Kittelmann B et al. Bladder tumours following chemotherapy and radiotherapy for ovarian cancer: a case-control study. Int J Cancer 1995 63 : 1 6
41. Neugut AI, Ahsan H, Robinson E, Ennis RD. Bladder carcinoma and other second malignancies after radiotherapy for prostate carcinoma. Cancer 1997 79 : 1600 4
42. Lucas SB. Squamous cell carcinoma of the bladder and schistosomiasis. East Afr Med J 1982 59 : 345 51
43. Bedwani R, Renganathan E, El Kwhsky F et al. Schistosomiasis and the risk of bladder cancer in Alexandria, Egypt. Br J Cancer 1998 77 : 1186 9
44. Gelfand M, Weinberg RW, Castle WM. Relation between carcinoma of the bladder and infestation with Schistosoma haematobium. Lancet 1967 1 : 1249 51
45. La Vecchia C, Negri E. Nutrition and bladder cancer. Cancer Causes Control 1996 7 : 95 100
46. Riboli E, Norat T. Epidemiologic evidence of the protective effect of fruit and vegetables on cancer risk. Am J Clin Nutr 2003 78 (Suppl. 559S 569S
47. Garcia-Closas R, Garcia-Closas M, Kogevinas M et al. Food, nutrient and heterocyclic amine intake and the risk of bladder cancer. Eur J Cancer 2007 43 : 1731 40
48. Glade MJ. Food, nutrition, and the prevention of cancer: a global perspective. American Institute for Cancer Research/World Cancer Research Fund, American Institute for Cancer Research, 1997. Nutrition 1999 15 : 523 6
49. Steinmaus CM, Nunez S, Smith AH. Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol 2000 151 : 693 702
50. Holick CN, De Vivo I, Feskanich D, Giovannucci E, Stampfer M, Michaud DS. Intake of fruits and vegetables, carotenoids, folate, and vitamins A, C, E and risk of bladder cancer among women (United States). Cancer Causes Control 2005 16 : 1135 45
51. WCRF/AICR. Food, Nutrition, Physical Activity, and Prevention of Cancer: a Global Perspective. Washington : American Institute for Cancer Research, 2007
52. Kang D, Park SK, Beane-Freeman L et al. Cancer incidence among pesticide applicators exposed to trifluralin in the Agricultural Health Study. Environ Res 2008 107 : 271 6
53. Jiang X, Castelao JE, Groshen S et al. Alcohol consumption and risk of bladder cancer in Los Angeles County. Int J Cancer 2007 121 : 839 45
54. Vineis P. Hypothesis: coffee consumption, N-acetyltransferase phenotype, and cancer. J Natl Cancer Inst 1993 85 : 1004 5
55. Sturgeon SR, Hartge P, Silverman DT et al. Associations between bladder cancer risk factors and tumor stage and grade at diagnosis. Epidemiology 1994 5 : 218 25
56. Weihrauch MR, Diehl V. Artificial sweeteners - do they bear a carcinogenic risk? Ann Oncol 2004 15 : 1460 5
57. Zeegers MP, Dorant E, Goldbohm RA, van den Brandt PA. Are coffee, tea, and total fluid consumption associated with bladder cancer risk? Results from the Netherlands Cohort Study. Cancer Causes Control 2001 12 : 231 8
58. Wannamethee SG, Shaper AG, Walker M. Physical activity and risk of cancer in middle-aged men. Br J Cancer 2001 85 : 1311 6
59. Tripathi A, Folsom AR, Anderson KE. Risk factors for urinary bladder carcinoma in postmenopausal women. The Iowa Women's Health Study. Cancer 2002 95 : 2316 23
60. Turesky RJ, Freeman JP, Holland RD et al. Identification of aminobiphenyl derivatives in commercial hair dyes. Chem Res Toxicol 2003 16 : 1162 73
61. La Vecchia C, Tavani A. Epidemiological evidence on hair dyes and the risk of cancer in humans. Eur J Cancer Prev 1995 4 : 31 43
62. Kogevinas M, Fernandez F, Garcia-Closas M et al. Hair dye use is not associated with risk for bladder cancer: evidence from a case-control study in Spain. Eur J Cancer 2006 42 : 1448 54
63. Lin J, Dinney CP, Grossman HB, Wu X. Personal permanent hair dye use is not associated with bladder cancer risk: evidence from a case-control study. Cancer Epidemiol Biomarkers Prev 2006 15 : 1746 9
64. Gago-Dominguez M, Castelao JE, Yuan JM, Yu MC, Ross RK. Use of permanent hair dyes and bladder-cancer risk. Int J Cancer 2001 91 : 575 9
65. Gago-Dominguez M, Bell DA, Watson MA et al. Permanent hair dyes and bladder cancer: risk modification by cytochrome P4501A2 and N-acetyltransferases 1 and 2. Carcinogenesis 2003 24 : 483 9
66. Kiemeney LA. Familial bladder cancer. In Lerner SP, Schoenberg M, Sternberg C, Textbook of Bladder Cancer. London : T & F-Informa, 2005 : 19 25
67. Aben KK, Witjes JA, Schoenberg MP, Hulsbergen-van de Kaa C, Verbeek AL, Kiemeney LA. Familial aggregation of urothelial cell carcinoma. Int J Cancer 2002 98 : 274 8
68. Murta-Nascimento C, Silverman DT, Kogevinas M et al. Risk of bladder cancer associated with family history of cancer: do low-penetrance polymorphisms account for the increase in risk? Cancer Epidemiol Biomarkers Prev 2007 16 : 1595 600
69. Guo Z, Linn JF, Wu G et al. CDC91L1 (PIG-U) is a newly discovered oncogene in human bladder cancer. Nat Med 2004 10 : 374 81
70. Rodriguez-Antona C, Ingelman-Sundberg M. Cytochrome P450 pharmacogenetics and cancer. Oncogene 2006 25 : 1679 91
71. Wu X, Zhao H, Suk R, Christiani DC. Genetic susceptibility to tobacco-related cancer. Oncogene 2004 23 : 6500 23
72. Wu X, Lin X, Dinney CP, Gu J, Grossman HB. Genetic polymorphism in bladder cancer. Front Biosci 2007 12 : 192 213
73. Chao C, Zhang ZF, Berthiller J, Boffetta P, Hashibe M. NAD(P)H quinone oxidoreductase 1 (NQO1) Pro187Ser polymorphism and the risk of lung, bladder, and colorectal cancers: a meta-analysis. Cancer Epidemiol Biomarkers Prev 2006 15 : 979 87
74. McIlwain CC, Townsend DM, Tew KD. Glutathione S-transferase polymorphisms: cancer incidence and therapy. Oncogene 2006 25 : 1639 48
75. Garcia-Closas M, Malats N, Silverman D et al. NAT2 slow acetylation, GSTM1 null genotype, and risk of bladder cancer: results from the Spanish Bladder Cancer Study and meta-analyses. Lancet 2005 366 : 649 59
76. Kellen E, Hemelt M, Broberg K et al. Pooled analysis and meta-analysis of the glutathione S-transferase P1 Ile 105Val polymorphism and bladder cancer: a HuGE-GSEC review. Am J Epidemiol 2007 165 : 1221 30
77. Deguchi T. Sequences and expression of alleles of polymorphic arylamine N-acetyltransferase of human liver. J Biol Chem 1992 267 : 18140 7
78. Gu J, Liang D, Wang Y, Lu C, Wu X. Effects of N-acetyl transferase 1 and 2 polymorphisms on bladder cancer risk in Caucasians. Mutat Res 2005 581 : 97 104
79. Wu X, Gu J, Grossman HB et al. Bladder cancer predisposition: a multigenic approach to DNA-repair and cell-cycle-control genes. Am J Hum Genet 2006 78 : 464 79
80. Andrew AS, Nelson HH, Kelsey KT et al. Concordance of multiple analytical approaches demonstrates a complex relationship between DNA repair gene SNPs, smoking and bladder cancer susceptibility. Carcinogenesis 2006 27 : 1030 7
81. Chen M, Kamat AM, Huang M et al. High-order interactions among genetic polymorphisms in nucleotide excision repair pathway genes and smoking in modulating bladder cancer risk. Carcinogenesis 2007 28 : 2160 5
82. Huang M, Dinney CP, Lin X, Lin J, Grossman HB, Wu X. High-order interactions among genetic variants in DNA base excision repair pathway genes and smoking in bladder cancer susceptibility. Cancer Epidemiol Biomarkers Prev 2007 16 : 84 91
83. Andrew AS, Karagas MR, Nelson HH et al. DNA repair polymorphisms modify bladder cancer risk: a multi-factor analytic strategy. Hum Hered 2008 65 : 105 18
84. Sak SC, Barrett JH, Paul AB, Bishop DT, Kiltie AE. DNA repair gene XRCC1 polymorphisms and bladder cancer risk. BMC Genet 2007 8 : 13
85. Figueroa JD, Malats N, Real FX et al. Genetic variation in the base excision repair pathway and bladder cancer risk. Hum Genet 2007 121 : 233 42
86. Garcia-Closas M, Malats N, Real FX et al. Genetic variation in the nucleotide excision repair pathway and bladder cancer risk. Cancer Epidemiol Biomarkers Prev 2006 15 : 536 42
87. Figueroa JD, Malats N, Rothman N et al. Evaluation of genetic variation in the double-strand break repair pathway and bladder cancer risk. Carcinogenesis 2007 28 : 1788 93
88. Hazra A, Chamberlain RM, Grossman HB, Zhu Y, Spitz MR, Wu X. Death receptor 4 and bladder cancer risk. Cancer Res 2003 63 : 1157 9
89. Leibovici D, Grossman HB, Dinney CP et al. Polymorphisms in inflammation genes and bladder cancer: from initiation to recurrence, progression, and survival. J Clin Oncol 2005 23 : 5746 56
90. Kiemeney LA, van Houwelingen KP, Bogaerts M et al. Polymorphisms in the E-cadherin (CDH1) gene promoter and the risk of bladder cancer. Eur J Cancer 2006 42 : 3219 27
91. Kader AK, Shao L, Dinney CP et al. Matrix metalloproteinase polymorphisms and bladder cancer risk. Cancer Res 2006 66 : 11644 8
92. Moore LE, Malats N, Rothman N et al. Polymorphisms in one-carbon metabolism and trans-sulfuration pathway genes and susceptibility to bladder cancer. Int J Cancer 2007 120 : 2452 8
93. Lin J, Spitz MR, Wang Y et al. Polymorphisms of folate metabolic genes and susceptibility to bladder cancer: a case-control study. Carcinogenesis 2004 25 : 1639 47
94. Berman DM, Wang Y, Liu Z et al. A functional polymorphism in RGS6 modulates the risk of bladder cancer. Cancer Res 2004 64 : 6820 6
95. Garcia-Closas M, Malats N, Real FX et al. Large-scale evaluation of candidate genes identifies associations between VEGF polymorphisms and bladder cancer risk. PLoS Genet 2007 3 : e29
96. Schabath MB, Spitz MR, Grossman HB et al. Genetic instability in bladder cancer assessed by the comet assay. J Natl Cancer Inst 2003 95 : 540 7
97. Wu X, Gu J, Spitz MR. Mutagen sensitivity: a genetic predisposition factor for cancer. Cancer Res 2007 67 : 3493 5
98. Wu X, Lin J, Grossman HB et al. Projecting individualized probabilities of developing bladder cancer in white individuals. J Clin Oncol 2007 25 : 4974 81
99. Lin J, Kadlubar FF, Spitz MR, Zhao H, Wu X. A modified host cell reactivation assay to measure DNA repair capacity for removing 4-aminobiphenyl adducts: a pilot study of bladder cancer. Cancer Epidemiol Biomarkers Prev 2005 14 : 1832 6
100. Wu X, Amos CI, Zhu Y et al. Telomere dysfunction: a potential cancer predisposition factor. J Natl Cancer Inst 2003 95 : 1211 8
101. Broberg K, Bjork J, Paulsson K, Hoglund M, Albin M. Constitutional short telomeres are strong genetic susceptibility markers for bladder cancer. Carcinogenesis 2005 26 : 1263 71
102. McGrath M, Wong JY, Michaud D, Hunter DJ, De Vivo I. Telomere length, cigarette smoking, and bladder cancer risk in men and women. Cancer Epidemiol Biomarkers Prev 2007 16 : 815 9